Literature DB >> 8791573

Periocular skin reshaping by CO2 laser coagulation.

M A Trelles, I Kaplan, J Rigau, O Buezo.   

Abstract

When blepharoplasty is performed by transconjunctival route, sometimes the excess of skin created by overlaxness of the lower lid does not retract to achieve the desired cosmetic result. We propose a method for controlled retraction of the eyelid by coagulating the skin using the CO2 laser. Thanks to this approach, the lower eyelid's tone recovers and the desired cosmetic appearance is achieved. Results of 37 patients that were treated by 10 W CO2 laser, 5-mm defocused beam diameter, and pulses of 100 ms, are presented. Follow-up shows that periocular skin reshaping by CO2 laser for laxened eyelid is a safe method and it can be considered a good alternative of treatment for blepharochalasis without skin excision.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8791573     DOI: 10.1007/bf00228465

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  6 in total

1.  Ultrapulse carbon dioxide laser removal of periocular wrinkles in association with laser blepharoplasty.

Authors:  C Weinstein
Journal:  J Clin Laser Med Surg       Date:  1994-08

2.  A simple, useful improvement of an eye protector.

Authors:  M A Trelles; W Verkruysse
Journal:  Ophthalmic Surg       Date:  1993-10

3.  Avoidance of complications in lower lid blepharoplasty.

Authors:  C D McCord; J W Shore
Journal:  Ophthalmology       Date:  1983-09       Impact factor: 12.079

4.  Reconsideration of fat pad management in lower lid blepharoplasty surgery.

Authors:  T A Cook; J Derebery; E R Harrah
Journal:  Arch Otolaryngol       Date:  1984-08

5.  Lower eyelid ectropion following chemical face peeling.

Authors:  T Wojno; R R Tenzel
Journal:  Ophthalmic Surg       Date:  1984-07

6.  Complications of chemical face peeling as evaluated by a questionnaire.

Authors:  C Litton; G Trinidad
Journal:  Plast Reconstr Surg       Date:  1981-06       Impact factor: 4.730

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.